$XNCR
Xencor Inc

2020 Q4 Form 10-Q Financial Statement

#000155837020012969 Filed on November 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $41.85M $35.40M $21.76M
YoY Change 1090.39% 62.68% -25.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.600M $7.600M $6.300M
YoY Change 13.43% 20.63% -14.86%
% of Gross Profit
Research & Development $47.90M $44.45M $29.77M
YoY Change 75.46% 49.32% 42.08%
% of Gross Profit
Depreciation & Amortization $1.500M $1.500M $1.100M
YoY Change 25.0% 36.36% 37.5%
% of Gross Profit
Operating Expenses $55.60M $52.09M $36.04M
YoY Change 63.05% 44.54% 26.94%
Operating Profit -$13.70M -$16.72M -$14.28M
YoY Change -55.19% 17.13% -2292.93%
Interest Expense $700.0K $1.400M $3.700M
YoY Change -79.41% -62.16% 42.31%
% of Operating Profit
Other Income/Expense, Net -$700.0K $4.172M $3.702M
YoY Change 12.7% 48.14%
Pretax Income -$13.70M -$12.55M -$10.57M
YoY Change -49.63% 18.69% -435.68%
Income Tax $0.00 $0.00 -$350.0K
% Of Pretax Income
Net Earnings -$13.69M -$12.55M -$10.22M
YoY Change -49.13% 22.75% -424.57%
Net Earnings / Revenue -32.71% -35.45% -46.99%
Basic Earnings Per Share -$0.24 -$0.22 -$0.18
Diluted Earnings Per Share -$0.24 -$0.22 -$0.18
COMMON SHARES
Basic Shares Outstanding 57.46M 57.27M 56.64M
Diluted Shares Outstanding 57.27M 56.64M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $603.0M $551.2M $546.5M
YoY Change 13.82% 0.86% 101.22%
Cash & Equivalents $163.5M $58.09M $51.19M
Short-Term Investments $439.5M $493.1M $495.3M
Other Short-Term Assets $10.70M $10.20M $7.500M
YoY Change 64.62% 36.0% -38.02%
Inventory
Prepaid Expenses
Receivables $11.44M $9.534M $4.349M
Other Receivables $0.00 $0.00 $500.0K
Total Short-Term Assets $637.7M $570.9M $573.8M
YoY Change 14.2% -0.5% 99.99%
LONG-TERM ASSETS
Property, Plant & Equipment $21.68M $19.77M $13.87M
YoY Change 37.18% 42.57% 42.97%
Goodwill
YoY Change
Intangibles $15.98M $15.32M $14.03M
YoY Change 10.79% 9.21%
Long-Term Investments $17.10M $31.80M $74.00M
YoY Change -76.08% -57.03% -73.21%
Other Assets $212.0K $8.608M $10.19M
YoY Change -31.83% -15.5% 3295.67%
Total Long-Term Assets $65.57M $75.47M $112.5M
YoY Change -41.37% -32.91% -62.34%
TOTAL ASSETS
Total Short-Term Assets $637.7M $570.9M $573.8M
Total Long-Term Assets $65.57M $75.47M $112.5M
Total Assets $703.2M $646.3M $686.2M
YoY Change 4.92% -5.81% 17.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.954M $13.11M $8.304M
YoY Change -12.12% 57.86% 38.4%
Accrued Expenses $17.60M $11.38M $7.832M
YoY Change 95.7% 45.31% 37.4%
Deferred Revenue $92.62M $43.84M $45.60M
YoY Change 104.9% -3.86%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $121.1M $70.49M $64.31M
YoY Change 81.89% 9.6% 23.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $9.700M $7.400M $11.70M
YoY Change -7.62% -36.75% 800.0%
Total Long-Term Liabilities $9.700M $7.400M $11.70M
YoY Change -7.62% -36.75% 800.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.1M $70.49M $64.31M
Total Long-Term Liabilities $9.700M $7.400M $11.70M
Total Liabilities $130.8M $77.87M $76.01M
YoY Change 69.76% 2.45% 42.6%
SHAREHOLDERS EQUITY
Retained Earnings -$365.7M -$352.0M -$269.5M
YoY Change 23.39% 30.63%
Common Stock $580.0K $573.0K $567.0K
YoY Change 1.93% 1.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $572.4M $568.5M $610.2M
YoY Change
Total Liabilities & Shareholders Equity $703.2M $646.3M $686.2M
YoY Change 4.92% -5.81% 17.19%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$13.69M -$12.55M -$10.22M
YoY Change -49.13% 22.75% -424.57%
Depreciation, Depletion And Amortization $1.500M $1.500M $1.100M
YoY Change 25.0% 36.36% 37.5%
Cash From Operating Activities $17.10M -$3.900M -$6.400M
YoY Change -187.24% -39.06% -37.86%
INVESTING ACTIVITIES
Capital Expenditures -$4.300M -$5.300M -$3.400M
YoY Change 19.44% 55.88% 142.86%
Acquisitions
YoY Change
Other Investing Activities $83.10M -$45.20M $25.40M
YoY Change 328.35% -277.95% 247.95%
Cash From Investing Activities $78.80M -$50.60M $22.10M
YoY Change 401.91% -328.96% 274.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.500M 3.000M 3.100M
YoY Change 216.67% -3.23% -26.19%
NET CHANGE
Cash From Operating Activities 17.10M -3.900M -6.400M
Cash From Investing Activities 78.80M -50.60M 22.10M
Cash From Financing Activities 9.500M 3.000M 3.100M
Net Change In Cash 105.4M -51.50M 18.80M
YoY Change -11811.11% -373.94% -9500.0%
FREE CASH FLOW
Cash From Operating Activities $17.10M -$3.900M -$6.400M
Capital Expenditures -$4.300M -$5.300M -$3.400M
Free Cash Flow $21.40M $1.400M -$3.000M
YoY Change -233.75% -146.67% -66.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
dei Entity Registrant Name
EntityRegistrantName
Xencor Inc
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57374937
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56902301
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
dei Entity Central Index Key
EntityCentralIndexKey
0001326732
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36182
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1622502
dei Entity Address Address Line1
EntityAddressAddressLine1
111 West Lemon Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Monrovia
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91016
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
305-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
XNCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57455204
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58094000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50312000
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
487688000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
479470000
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5382000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9534000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21574000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
502000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10185000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6547000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
570883000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
558405000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19771000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15805000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15319000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14421000
CY2020Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
31768000
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
71526000
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
402000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8608000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9691000
CY2020Q3 us-gaap Assets
Assets
646349000
CY2019Q4 us-gaap Assets
Assets
670250000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13109000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10189000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11381000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8995000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2158000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2169000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43840000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45205000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
70488000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66558000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7378000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8565000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1926000
CY2020Q3 us-gaap Liabilities
Liabilities
77866000
CY2019Q4 us-gaap Liabilities
Liabilities
77049000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57374937
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56902301
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
573000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
569000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
919387000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
887873000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
567000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1161000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-352044000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296402000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
568483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153184000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
646349000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
670250000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35366000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21760000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80840000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44452000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29770000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121853000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91250000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7636000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6266000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22086000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17537000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
52088000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
36036000
us-gaap Operating Expenses
OperatingExpenses
143939000
us-gaap Operating Expenses
OperatingExpenses
108787000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16722000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14276000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63099000
us-gaap Operating Income Loss
OperatingIncomeLoss
44397000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1423000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3699000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6552000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
10201000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2749000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
905000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-211000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4172000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3702000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7457000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9990000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12550000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10574000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55642000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54387000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-350000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-12550000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-10224000
us-gaap Net Income Loss
NetIncomeLoss
-55642000
us-gaap Net Income Loss
NetIncomeLoss
53787000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3049000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10417000
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-916000
CY2019Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-193000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-594000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2407000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13466000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10417000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-56236000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56194000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57266112
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56643075
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57091452
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56449678
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57266112
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56643075
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57091452
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58365158
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1471000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8179000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6512000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
593005000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3275000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
725000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34591000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8231000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
570645000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2986000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13466000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8318000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
568483000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
667000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
81361000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5856000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
609565000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3239000
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
734000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14750000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9303000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
608091000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9514000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
610237000
us-gaap Profit Loss
ProfitLoss
-55642000
us-gaap Profit Loss
ProfitLoss
53787000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4262000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3073000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
981000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3333000
us-gaap Share Based Compensation
ShareBasedCompensation
23061000
us-gaap Share Based Compensation
ShareBasedCompensation
24673000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
403000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
115000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4589000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
794000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-8000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
153000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-12040000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-5903000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-1135000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
3000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-53000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
15000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3629000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2843000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2920000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4508000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2386000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1830000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
895000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1204000
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
-168000
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
-110000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3291000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
8113000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22088000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83951000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
477310000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
352174000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2143000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2932000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7390000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4443000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
508256000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
292852000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
21413000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66697000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7732000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
6955000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
725000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
734000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8457000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7689000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7782000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50312000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24943000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26246000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58094000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51189000
us-gaap Interest Paid Net
InterestPaidNet
15000
us-gaap Interest Paid Net
InterestPaidNet
11000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
200000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-594000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
2407000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:36pt;margin:0pt;"><span style="font-size:10pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, intangible assets and related amortization. Significant estimates in these interim financial statements include estimates made for royalties and accrued research and development expenses, stock-based compensation expenses, intangible assets and related amortization, estimated standalone selling price of performance obligations, the likelihood of recognizing variable consideration, and recoverability of deferred tax assets.</p>
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2019Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2020Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2019Q3 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2020Q3 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5382000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
559350000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
583005000
CY2019Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12550000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10224000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55642000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
53787000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57266112
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56643075
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57091452
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56449678
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1915480
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57266112
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56643075
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57091452
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58365158
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
998186
CY2020Q3 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
553391000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
581000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2020Q3 us-gaap Investments
Investments
553968000
CY2020Q3 us-gaap Investments
Investments
553968000
CY2019Q4 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
581834000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1201000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
487108000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
487688000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
31771000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
31768000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
518879000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
519456000
CY2020Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2800000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
800000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8318000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9514000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23061000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24673000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8318000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9514000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23061000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24673000
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
655000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2647000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2269000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1415000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1436000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1330000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1238000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10990000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1454000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9536000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2158000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7378000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
9536000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
599000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
648000
us-gaap Operating Lease Cost
OperatingLeaseCost
1896000
us-gaap Operating Lease Cost
OperatingLeaseCost
1948000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
70000
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
11000
us-gaap Variable Lease Cost
VariableLeaseCost
129000
us-gaap Variable Lease Cost
VariableLeaseCost
67000
CY2020Q3 us-gaap Lease Cost
LeaseCost
669000
CY2019Q3 us-gaap Lease Cost
LeaseCost
659000
us-gaap Lease Cost
LeaseCost
2025000
us-gaap Lease Cost
LeaseCost
2015000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
527000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
531000
us-gaap Operating Lease Payments
OperatingLeasePayments
1650000
us-gaap Operating Lease Payments
OperatingLeasePayments
1385000
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
300000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
400000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35400000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21800000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80800000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153200000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35400000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21800000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80800000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
153200000
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
43800000
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
48200000
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45600000
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2600000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000

Files In Submission

Name View Source Status
0001558370-20-012969-index-headers.html Edgar Link pending
0001558370-20-012969-index.html Edgar Link pending
0001558370-20-012969.txt Edgar Link pending
0001558370-20-012969-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xncr-20200930.xsd Edgar Link pending
xncr-20200930x10q.htm Edgar Link pending
xncr-20200930x10q_htm.xml Edgar Link completed
xncr-20200930xex10d1.htm Edgar Link pending
xncr-20200930xex10d2.htm Edgar Link pending
xncr-20200930xex31d1.htm Edgar Link pending
xncr-20200930xex31d2.htm Edgar Link pending
xncr-20200930xex32d1.htm Edgar Link pending
xncr-20200930_cal.xml Edgar Link unprocessable
xncr-20200930_def.xml Edgar Link unprocessable
xncr-20200930_lab.xml Edgar Link unprocessable
xncr-20200930_pre.xml Edgar Link unprocessable